VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XRAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XRAYDENTSPLY SIRONA Inc.
$11.65$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

XRAY logoDENTSPLY SIRONA Inc.(XRAY)Earnings, Financials & Key Ratios

XRAY•NASDAQ
$11.09
Price updated Jul 2, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDental and vision care devices
AboutDENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.Show more
  • Revenue$3.68B-3.0%
  • EBITDA$604M+214.0%
  • Net Income-$598M+34.3%
  • EPS (Diluted)-3.00+33.0%
  • Gross Margin50%-3.1%
  • EBITDA Margin16.41%+217.5%
  • Operating Margin6.85%+129.5%
  • Net Margin-16.25%+32.3%
  • ROE-36.43%-4.8%

XRAY Price & Volume

DENTSPLY SIRONA Inc. (XRAY) stock price & volume — 10-year historical chart

Loading chart...

Persistent Structural Impairment Clouds Operational Recovery Outlook

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Deteriorating
Primary Risk:Persistent Structural Impairment Charges

Key Thesis Takeaways

  • DENTSPLY SIRONA faces a challenging turnaround as stagnant revenue growth and persistent operational losses continue to erode the company's equity base.
  • While the firm attempts to stabilize its core dental equipment segment, the combination of high SG&A expenses and significant goodwill write-downs suggests that long-term competitive relevance remains under pressure.
  • Investors should remain cautious as the company navigates a volatile liquidity environment and a deteriorating capital structure.

Verdict Logic

the company's equity base has plummeted from $3.3 billion in 2023Q4 to $1.3 billion in 2026Q1, signaling severe structural risks that outweigh the current dividend yield.

XRAY Growth Metrics

DENTSPLY SIRONA Inc. (XRAY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.24%
5 Years1.96%
3 Years-2.1%
TTM-1.02%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM30.84%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM30.61%

Return on Capital

10 Years-3.41%
5 Years-3.6%
3 Years-4.22%
Last Year6.11%

XRAY Recent Earnings

DENTSPLY SIRONA Inc. (XRAY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 6/12 qtrs (55%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.27-3.6%
$0.28
Rev
$880M+4.5%
$842M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$0.27-3.6%
$0.28
Rev
$961M+3.8%
$926M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.37-17.8%
$0.45
Rev
$904M-2.5%
$927M
Q3 2025
Aug 7, 2025
Metric
Actual
Est
EPS
$0.52+4.0%
$0.50
Rev
$936M+3.5%
$905M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.27vs $0.28-3.6%
$880Mvs $842M+4.5%
Q1 2026Feb 26, 2026
$0.27vs $0.28-3.6%
$961Mvs $926M+3.8%
Q4 2025Nov 6, 2025
$0.37vs $0.45-17.8%
$904Mvs $927M-2.5%
Q3 2025Aug 7, 2025
$0.52vs $0.50+4.0%
$936Mvs $905M+3.5%
Based on last 12 quarters of dataView full earnings history →

Latest XRAY News

Recent stock market news and headlines for DENTSPLY SIRONA Inc. (XRAY)

GlobeNewsWire·4 days ago
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients.

Peers Comparison

Key metrics vs top competitors for DENTSPLY SIRONA Inc. (XRAY)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
XRAY logoXRAYDENTSPLY SIRONA Inc.Current
$11.09$2.22B-3.70-2.98%-16.25%-36.43%5.79%
ALGN logoALGNAlign Technology, Inc.
$181.49$13B32.120.9%10.5%10.7%—
HSIC logoHSICHenry Schein, Inc.
$84.52$9.63B25.854.03%2.95%8.14%—
NVST logoNVSTEnvista Holdings Corp
$27.17$4.43B97.048.32%2.41%2.18%—
MMSI logoMMSIMerit Medical Systems, Inc.
$69.45$4.14B32.6111.66%9.03%8.95%—
HOLX logoHOLXHologic, Inc.
$76.01$16.97B30.531.74%13.18%11.01%—

Compare XRAY vs Peers

DENTSPLY SIRONA Inc. (XRAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ALGN

Most directly comparable listed peer for XRAY.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare XRAY against a more recognizable public peer.

Peer Set

Compare Top 5

vs ALGN, HSIC, NVST, MMSI

XRAY SEC Filings & Documents

DENTSPLY SIRONA Inc. (XRAY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Feb 24, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

10-Q Quarterly Reports

4
FY 2026

May 5, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when XRAY posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

XRAY Frequently Asked Questions

DENTSPLY SIRONA Inc. (XRAY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is DENTSPLY SIRONA Inc.'s revenue?

DENTSPLY SIRONA Inc. (XRAY) reported $3.68B in revenue for fiscal year 2025. This represents a 461% increase from $656.6M in 1996.

How fast is DENTSPLY SIRONA Inc. growing?

DENTSPLY SIRONA Inc. (XRAY) saw revenue decline by 3.0% over the past year.

Is XRAY profitable?

DENTSPLY SIRONA Inc. (XRAY) reported a net loss of $628.0M for fiscal year 2025.

Dividend & Returns
Does XRAY pay dividends?

Yes, DENTSPLY SIRONA Inc. (XRAY) pays a dividend with a yield of 5.79%. This makes it attractive for income-focused investors.

What is XRAY's return on equity?

DENTSPLY SIRONA Inc. (XRAY) has a return on equity (ROE) of -36.4%. Negative ROE indicates the company is unprofitable.

What is DENTSPLY SIRONA Inc.'s free cash flow?

DENTSPLY SIRONA Inc. (XRAY) generated $104.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in XRAY back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →